{"data":{"id":"us-il/305-ilcs-65-15","jurisdiction":"us-il","citation":"305 ILCS 65/15","heading":"Availability of naloxone formulations.","body":"The Department of Human Services shall, as part of the fiscal year 2024 Drug Overdose Prevention Program, make all FDA-approved formulations of naloxone that are cleared through the Minnesota Multistate Contracting Alliance for Pharmacy, and for which the manufacturer can set up a system for receiving, tracking, and distribution, available to eligible Drug Overdose Prevention Program participants and applicants.","path":["CHAPTER 305 PUBLIC AID","Early Mental Health and Addictions Treatment Act."],"source_url":"https://www.ilga.gov/legislation/ILCS/details?ActID=3899\u0026ChapterID=28\u0026ChapAct=FullText\u0026Print=True","current_through":"at least Public Act 104-790","vintage":"","retrieved_at":"2026-09-15T04:46:32Z","sha256":"850db974722a3d3055a6c8ca9416bc5fd61dcca65a7c9266ad3b6bab625f8357","source_id":"us-il","stale":false,"prev":"us-il/305-ilcs-65-10","next":"us-il/305-ilcs-65-99"},"notice":"GroundRules: Original legal text. Not legal advice."}